Jaguar Health (JAGX) Receivables - Net (2015 - 2026)

Jaguar Health (JAGX) has 12 years of Receivables - Net data on file, last reported at $68000.0 in Q1 2026.

• On a quarterly basis, Receivables - Net fell 94.44% year-over-year to $68000.0 in Q1 2026; TTM through Mar 2026 was $68000.0, a 94.44% decrease from a year earlier, with the FY2025 full-year figure at $1.5 million, changed 0.39% from the prior year.
• Receivables - Net for Q1 2026 stood at $68000.0, down from $1.5 million in the prior quarter.
• Over the last five years, Receivables - Net for JAGX reached as high as $2.0 million in Q4 2023 and fell as low as $68000.0 in Q1 2026.
• Historically, Receivables - Net has averaged $1.4 million across 5 years, with a median of $1.5 million in 2024.
• Across the five-year window, Receivables - Net soared 53.19% in 2024 and tumbled 94.44% in 2026, its largest moves.
• Year by year, Receivables - Net stood at $1.9 million in 2022, then climbed by 4.68% to $2.0 million in 2023, then declined by 22.37% to $1.5 million in 2024, then slipped by 0.39% to $1.5 million in 2025, then slumped by 95.53% to $68000.0 in 2026.
• Per Business Quant data, the three most recent Receivables - Net figures were $68000.0 in Q1 2026, $1.5 million in Q4 2025, and $1.4 million in Q3 2025.